Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeutics.

Gut microbiota plays key functions in the human body, and its alteration is associated with several human disorders. Moreover, its manipulation is being investigated as a potential therapeutic strategy. In this narrative review we will dissect the involvement of the gut microbiota and of the gut-liver axis on metabolic dysfunction-associated steatotic liver disease (MASLD).

Bubble dynamics manipulation in polymeric foaming.

The release of pressure from a high-pressure-stable polymer/gas solution is a common method for creating gas bubbles and forming foam with a typical polyhedral cell structure. We propose a new approach to control the foaming process by pausing the bubble growth at intermediate pressure before reaching ambient pressure. This allows us to control the growth of the bubbles and investigate various physical phenomena involved in polymer foaming, such as Ostwald ripening, bubble interactions, coalescence, and different bubble growth regimes.

Genomic and Socioeconomic Determinants of Racial Disparities in Breast Cancer Survival: Insights from the All of Us Program.

: Breast cancer outcomes are worse among Black women in the U.S. compared to White women.

Non-Alcoholic Steatohepatitis Patient Characterization and Real-World Management Approaches in Italy.

Background: Although the estimated prevalence of non-alcoholic steatohepatitis (NASH) in Italy is 4-6%, little is known about patient characteristics and care pathways.

Aim: To describe patient characteristics and management approaches for patients with NASH or suspected NASH in Italy.

Methods: Data were drawn from the Adelphi Real World NASH Disease Specific Programme™, a cross-sectional survey of endocrinologists and gastroenterologists in Italy from January to March 2018.